3.595
Schlusskurs vom Vortag:
$3.52
Offen:
$3.51
24-Stunden-Volumen:
801.44K
Relative Volume:
1.21
Marktkapitalisierung:
$374.19M
Einnahmen:
$251.42M
Nettoeinkommen (Verlust:
$-202.39M
KGV:
-2.0197
EPS:
-1.78
Netto-Cashflow:
$38.21M
1W Leistung:
-7.35%
1M Leistung:
-8.29%
6M Leistung:
-31.39%
1J Leistung:
-3.62%
Definitive Healthcare Corp Stock (DH) Company Profile
Firmenname
Definitive Healthcare Corp
Sektor
Branche
Telefon
508-720-4224
Adresse
492 OLD CONNECTICUT PATH, SUITE 401, FRAMINGHAM
Vergleichen Sie DH mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
DH
Definitive Healthcare Corp
|
3.595 | 414.34M | 251.42M | -202.39M | 38.21M | -1.78 |
![]()
VEEV
Veeva Systems Inc
|
275.43 | 46.10B | 2.86B | 780.66M | 1.20B | 4.72 |
![]()
TEM
Tempus Ai Inc
|
66.34 | 10.54B | 803.32M | -709.10M | -212.68M | -7.8003 |
![]()
DOCS
Doximity Inc
|
61.82 | 12.48B | 550.17M | 201.35M | 232.07M | 1.00 |
![]()
HQY
Healthequity Inc
|
92.98 | 8.05B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
WAY
Waystar Holding Corp
|
34.58 | 6.03B | 906.14M | -52.62M | 89.62M | -0.3621 |
Definitive Healthcare Corp Stock (DH) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-05-09 | Herabstufung | BTIG Research | Buy → Neutral |
2025-01-13 | Herabstufung | Barclays | Equal Weight → Underweight |
2024-12-20 | Eingeleitet | Stephens | Equal-Weight |
2024-09-17 | Eingeleitet | BTIG Research | Buy |
2024-07-31 | Herabstufung | JP Morgan | Neutral → Underweight |
2024-05-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
2024-01-17 | Herabstufung | Needham | Buy → Hold |
2024-01-05 | Herabstufung | Canaccord Genuity | Buy → Hold |
2023-07-24 | Herabstufung | Robert W. Baird | Outperform → Neutral |
2023-04-19 | Eingeleitet | William Blair | Outperform |
2022-12-09 | Eingeleitet | BofA Securities | Neutral |
2022-07-06 | Eingeleitet | Needham | Buy |
2022-04-01 | Fortgesetzt | Credit Suisse | Neutral |
2022-02-24 | Hochstufung | Canaccord Genuity | Hold → Buy |
2021-12-16 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
2021-12-02 | Eingeleitet | Jefferies | Buy |
2021-11-17 | Eingeleitet | Robert W. Baird | Outperform |
2021-10-11 | Eingeleitet | Barclays | Equal Weight |
2021-10-11 | Eingeleitet | Canaccord Genuity | Hold |
2021-10-11 | Eingeleitet | Credit Suisse | Neutral |
2021-10-11 | Eingeleitet | Deutsche Bank | Hold |
2021-10-11 | Eingeleitet | Goldman | Neutral |
2021-10-11 | Eingeleitet | JP Morgan | Neutral |
2021-10-11 | Eingeleitet | Morgan Stanley | Equal-Weight |
2021-10-11 | Eingeleitet | Raymond James | Mkt Perform |
2021-10-11 | Eingeleitet | Stifel | Buy |
Alle ansehen
Definitive Healthcare Corp Aktie (DH) Neueste Nachrichten
Custom strategy builders for tracking Definitive Healthcare Corp.Buy and Hold Strategy for Capital Safety - Newser
Definitive Healthcare Corp (DH) Stock: Navigating a Year of Volatility - investchronicle.com
Using Python tools to backtest Definitive Healthcare Corp. strategiesDay Trading Plan with Entry Risk Management - Newser
Comparing Definitive Healthcare Corp. in custom built stock radarsAI Trade Signal Forecast with Chart Logic - Newser
Is Definitive Healthcare Corp. a candidate for recovery playFree Swing Trading Plan With Smart Signals - Newser
What’s the recovery path for long term holders of Definitive Healthcare Corp.Buy Strategy with Smart Exit Timing - Newser
Understanding Definitive Healthcare Corp.’s price movementFree Step-by-Step Stock Investment Guide - Newser
Sectors Driving Future Growth for Definitive Healthcare Corp. StockDaily Swing Candidate Analysis with Chart Patterns - Newser
Chart overlay techniques for tracking Definitive Healthcare Corp.Free Earnings Play Trade Plan With Alerts - Newser
Is Definitive Healthcare Corp. forming a reversal patternFree Top Gaining Picks With Entry Signals - Newser
Deutsche Bank Adjusts Definitive Healthcare Price Target to $5 From $4, Maintains Hold Rating - MarketScreener
Definitive Healthcare Corp: Hold Rating Amid Mixed Performance and Future Uncertainties - TipRanks
Can trapped investors hope for a rebound in Definitive Healthcare Corp.Free AI Powered High Return Stock Calls - Newser
Multi asset correlation models including Definitive Healthcare Corp.Capital Protection Strategy With Risk Analysis - Newser
Published on: 2025-08-11 00:06:40 - Newser
Using data models to predict Definitive Healthcare Corp. stock movementStock Market Trend and Pattern Analysis - Newser
Exit strategy if you’re trapped in Definitive Healthcare Corp.Free Low Capital High Return Stock Plans - Newser
Developing predictive dashboards with Definitive Healthcare Corp. dataFree Secure Capital Picks With Upside Potential - Newser
Definitive Healthcare raises full-year revenue guidance to $237M-$240M driven by improved retention - MSN
Definitive Healthcare Corp. (NASDAQ:DH) Analysts Are Pretty Bullish On The Stock After Recent Results - 富途牛牛
Stifel Nicolaus Forecasts Strong Price Appreciation for Definitive Healthcare (NASDAQ:DH) Stock - Defense World
Why Definitive Healthcare Corp. stock is on top investor watchlistsFree Weekly Setup With 3x Return Potential - Newser
Is this a good reentry point in Definitive Healthcare Corp.Free Weekly Return Pick Forecast Reports - Newser
Definitive Healthcare Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Definitive Healthcare Corp. (NASDAQ:DH) Q2 2025 Earnings Call Transcript - Insider Monkey
Definitive Healthcare's Q2 2025 Earnings Call: Unpacking Contradictions in Sales Cycles, Customer Retention, and Market Demand - AInvest
Definitive Healthcare Corp. (DH) Q2 Earnings and Revenues Top Estimates - NewsBreak: Local News & Alerts
Definitive Healthcare price target raised to $4 from $3 at Baird - TipRanks
BofA Securities reiterates Buy rating on Definitive Healthcare stock By Investing.com - Investing.com Nigeria
Earnings call transcript: Definitive Healthcare Q2 2025 earnings beat forecasts By Investing.com - Investing.com Nigeria
Earnings call transcript: Definitive Healthcare Q2 2025 earnings beat forecasts - Investing.com India
Stifel raises Definitive Healthcare stock price target to $6 on improved retention - Investing.com Nigeria
Cautious Optimism for Definitive Healthcare Corp Amid Market Strategy Revitalization and Customer Retention Challenges - TipRanks
Definitive Healthcare Q2 2025 slides: revenue decline continues but exceeds guidance - Investing.com
Definitive Healthcare Raises FY22 Revenue Guidance to $237M-$240M, Citing Improved Retention - AInvest
Definitive Healthcare Corp (DH) Q2 2025 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada
Definitive Healthcare Exceeds Revenue Guidance, Cuts Net Loss in Q2 2025 - AInvest
Definitive Healthcare Reports Q2 2025 Results - TipRanks
Definitive Healthcare Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Why Definitive Healthcare Corp. stock attracts strong analyst attentionRisk Aware Swing Trade Analysis Insights - Newser
Definitive Healthcare earnings beat by $0.02, revenue topped estimates - Investing.com
Detecting price anomalies in Definitive Healthcare Corp. with AIAI Powered Stock Market Trend Forecast - Newser
Definitive Healthcare Reports Financial Results for Second Quarter Fiscal Year 2025 - TradingView
Definitive Healthcare Q2 revenue beats expectations - MarketScreener
Press Release: Definitive Healthcare Reports Financial Results for Second Quarter Fiscal Year 2025 - 富途牛牛
Finanzdaten der Definitive Healthcare Corp-Aktie (DH)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):